<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The political and economic situation, as well as climate changes in many regions of the world, pushing hundreds of thousands of people to leave their homes. This changes the epidemiological situation and facilitates the spread of diseases including tuberculosis (TB). The emergence of multi-and extremely-drug-resistant 
 <italic class="italic">Mycobacterium tuberculosis</italic> (Mtb) strains makes TB the global threat. Rifampicin, the last breakthrough drug, was introduced in the 1960s. The limited commercial potential for anti-TB therapies and noticeable withdrawal of pharmaceutical companies from antibacterial drug research make the situation even more disturbing.
</p>
